“Increasingly, bioconvergent therapeutics and hybrid products and services promise cures; with current pharmaco-economic pricing rationales, these will be cost-effective but they will
bankrupt the system.”
“Helping clients around the globe to unleash the power of immune system in the fight against a plethora of diseases is a very rewarding career path for a trained immunologist.”
“Is biopharma ready to embrace the new biology?”
“Change-Management is a team effort – let’s get started.”
“Catenion provides an exciting workplace where science meets business. We aim to help our clients to reach patients sooner and better.”
“Translating new technologies into viable business ideas”
“We develop strategies that empower our clients to drive innovation and bring new treatments from promises to patients.”
“Enhance decision making through a data-driven approach: challenging assumptions and exploring new ideas – this is our passion.”
“At Catenion, I can put my scientific background in cell therapy and regenerative medicine to practical use and help bring innovative therapies to the market.”
“Catenion’s approach to assessing risk and value on both a project and portfolio level goes way beyond what is usually discussed in senior executive teams. It has allowed us to create a very solid foundation of information, which is the key to understanding the portfolio. Their process and independent points of view have greatly helped our Executive Management Board take difficult decisions during a challenging post–merger review of the portfolio, and going forward we have decided to implement their approach as the framework for us to manage our portfolio.”
